A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in ...
Intensity-modulated radiotherapy is as good as proton beam therapy for treating people with head and neck cancer, according ...
Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...
Proton therapy did not outperform IMRT in quality-of-life outcomes for patients with oropharyngeal cancer. Both treatments achieved similarly strong control and survival, according to new trial ...
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, ...
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma Clinical trials frequently include multiple ...
Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...
Treatment depends on the sarcoma’s type, location, grade, and stage, as well as the patient’s overall health and goals of care. Many patients benefit from a team approach that includes oncologists, ...
HealthDay News — In a clinical practice guideline published online Sept. 16 in Practical Radiation Oncology, recommendations are presented for the use of postmastectomy radiation therapy (PMRT).
Intensity-modulated radiation therapy did not increase the risk for feeding tube dependence for patients with oropharyngeal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback